X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

NUCLEAR MEDICINE AND BIOLOGY

期刊標題檢索 NUCL MED BIOL 最新評論: Keywords are often the words that appear most frequently in the text; ... (2021-12-30)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[NUCLEAR MEDICINE AND BIOLOGY]您好,您是該頁面的第 20609 位訪客。

期刊簡介
期刊名稱NUCLEAR MEDICINE AND BIOLOGY NUCLEAR MEDICINE AND BIOLOGY
LetPub Score
6.2
50 ratings
Rate

Reputation
7.6

Influence
4.9

Speed
7.0

期刊簡稱NUCL MED BIOL
ISSN0969-8051
E-ISSN1872-9614
h-index82
CiteScore
CiteScoreSJRSNIPCiteScore Rank
6.000.6580.787
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Radiology, Nuclear Medicine and Imaging
Q171 / 333
Category: Medicine
Subcategory: Cancer Research
Q2107 / 230
Category: Medicine
Subcategory: Molecular Medicine
Q289 / 178

自引率 (2023-2024)5.60%自引率趨勢
掲載範囲
Nuclear Medicine and Biology publishes original research addressing all aspects of radiopharmaceutical science: synthesis, in vitro and ex vivo studies, in vivo biodistribution by dissection or imaging, radiopharmacology, radiopharmacy, and translational clinical studies of new targeted radiotracers. The importance of the target to an unmet clinical need should be the first consideration. If the synthesis of a new radiopharmaceutical is submitted without in vitro or in vivo data, then the uniqueness of the chemistry must be emphasized.

These multidisciplinary studies should validate the mechanism of localization whether the probe is based on binding to a receptor, enzyme, tumor antigen, or another well-defined target. The studies should be aimed at evaluating how the chemical and radiopharmaceutical properties affect pharmacokinetics, pharmacodynamics, or therapeutic efficacy. Ideally, the study would address the sensitivity of the probe to changes in disease or treatment, although studies validating mechanism alone are acceptable. Radiopharmacy practice, addressing the issues of preparation, automation, quality control, dispensing, and regulations applicable to qualification and administration of radiopharmaceuticals to humans, is an important aspect of the developmental process, but only if the study has a significant impact on the field.

Contributions on the subject of therapeutic radiopharmaceuticals also are appropriate provided that the specificity of labeled compound localization and therapeutic effect have been addressed.
官方網站http://www.journals.elsevier.com/nuclear-medicine-and-biology/
在線稿件提交https://www.editorialmanager.com/NUCMEDBIO
開放訪問No
出版商Elsevier Inc.
主題領域医学
出版國/地區UNITED STATES
發行頻率隔月刊行
創刊年1993
每年文章數38每年文章數趨勢
黃金OA百分比35.59%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGINGSCIEQ136/204
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0969-8051%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Ordinary, 3-8 Week(s)
來自Elsevier的數據: Average 8 Week(s)
競爭力 *來自作者的數據: Easy
在線文章發布時間來自Elsevier的數據: Average 6.7 Week(s)
參考鏈接
相關期刊 【NUCLEAR MEDICINE AND BIOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    RADIOLOGYH-index: 271

    CiteScore: 35.20
    Radiologia MedicaH-index: 41

    CiteScore: 14.10
    CLINICAL NUCLEAR MEDICINEH-index: 53

    CiteScore: 2.90
    JOURNAL OF NUCLEAR MEDICINEH-index: 195

    CiteScore: 13.00
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGINGH-index: 153

    CiteScore: 15.60
    INVESTIGATIVE RADIOLOGYH-index: 103

    CiteScore: 15.10
    Circulation-Cardiovascular ImagingH-index: 83

    CiteScore: 6.30
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSH-index: 228

    CiteScore: 11.00
    COMPUTERIZED MEDICAL IMAGING AND GRAPHICSH-index: 63

    CiteScore: 10.70
    RADIOGRAPHICSH-index: 151

    CiteScore: 8.20
    學科內最受檢索的期刊 頁面查看次數
    MEDICAL PHYSICS173440
    NEUROIMAGE157200
    ULTRASONICS132965
    EUROPEAN RADIOLOGY114947
    RADIOLOGY112328
    COMPUTERIZED MEDICAL IMAGING AND GRAPHICS103797
    EUROPEAN JOURNAL OF RADIOLOGY91835
    HUMAN BRAIN MAPPING83437
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS71122
    JOURNAL OF MAGNETIC RESONANCE IMAGING68105
  •  

    NUCLEAR MEDICINE AND BIOLOGY NUCLEAR MEDICINE AND BIOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [NUCLEAR MEDICINE AND BIOLOGY] 的評論撰寫評論
作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 16:28:35 評論於
Keywords are often the words that appear most frequently in the text; Keywords are words that can represent the essence of your paper, making it easier to find and increasing the chances of citation
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 09:03:58 評論於
In the medical field, most journals and clinical papers specifically recommend MeSH. The use of MeSH terms is to assist in literature searching and increase the weight of publications
(0) 讚! | 维尔娜菲茨杰拉德

作者: Oswald Edie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 19:28:18 評論於
What are the requirements for keyword selection?
(0) 讚! | Oswald Edie

作者: 陶宜三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 15:02:02 評論於
Why should we filter keywords from MeSH?
(0) 讚! | 陶宜三岁啦

作者: 雅松可爱吗


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-12-27 10:42:37 評論於
Review speed: 1.0 | Submission success rate: 5.0
Experience sharing: Rejected after three days of submission
(0) 讚! | 雅松可爱吗

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-18 21:47:58 評論於
Although there are no major changes this year, we will see in the future
(0) 讚! | 凌霄高洁

作者: 匿名


領域: 医药科学
審稿時間: 0.0 month(s)
結果:


撰寫評論

2013-08-02 11:25:00 評論於
Very slow, only one reviewer.It is also very slow from reception to final publication, about two months.After submitting the manuscript to the end, it has basically passed for half a year.
(0) 讚! | 匿名

作者: 北风滨海


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-08-02 08:24:37 評論於
Very slow, with only one reviewer. It also took a very long time from submission to final publication, about two months. It took almost half a year from submission to final publication
(0) 讚! | 北风滨海

作者: 匿名


領域: 放射性药物
審稿時間: 0.0 month(s)
結果:


撰寫評論

2011-01-05 17:57:00 評論於
The old nuclear medicine journal focuses on radiochemical synthesis and biological evaluation. Although IF is not high, it is strict.
(0) 讚! | 匿名

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2010-05-07 18:02:17 評論於
Entering under review status was quick, but the review time has been going on for three months now, and still no news. I've sent a reminder once, but still no response
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [NUCLEAR MEDICINE AND BIOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*